Patent ID: 8722085
Filing Date: 2014-05-13
Classification: A61J,A61K,A61P,B65D

Abstract:
1. A method of administering a pharmaceutical formulation to an individual, comprising: administering a first unit dosage every day for a first week, wherein the first unit dosage comprises about 90 mg of bupropion and an amount of naltrexone selected from the group consisting of about 4 mg and about 8 mg; administering a second unit dosage every day for a second week, wherein the second unit dosage comprises bupropion and naltrexone, and wherein the second unit dosage comprises about twice as much bupropion and about twice as much naltrexone as the first unit dosage; administering a third unit dosage every day for a third week, wherein the third unit dosage comprises bupropion and naltrexone, and wherein the third unit dosage comprises about three times as much bupropion and about three times as much naltrexone as the first unit dosage; and administering a fourth unit dosage every day for a fourth week, wherein the fourth unit dosage comprises bupropion and naltrexone, and wherein the fourth unit dosage comprises about four times as much bupropion and about four times as much naltrexone as the first unit dosage.